Key Takeaways Abbott's Nutrition business expands on strong global demand despite some softness in pediatrics. ABT's adult Nutrition grew 6.6% organically in Q2 2025, leading overall segment growth.ABT's Ensure and Glucerna continue to fuel demand, while Similac remains strong in the U.S. market.Abbott Laboratories’ (ABT) Nutrition business has consistently demonstrated strong growth and market share gains. This segment offers a broad line of pediatric and adult nutritional products. Despite some ongoing so ...